Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Samsung, Biogen Co-Operate Amid Italian Antitrust Investigation Into Biosimilar Lucentis
Byooviz Biosimilar Not Available In Italy After August 2021 MAA; Conduct ‘Anomalous’
Jun 10 2024
•
By
Dean Rudge
• Source: Shutterstock
More from Regulation
More from Policy & Regulation
